Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
Matthias J Koepp, Eugen Trinka, Yee-Haur Mah, Carla Bentes, Susanne Knake, Gian Luigi Gigli, José M Serratosa, Johan Zelano, Robert Simister, Francesco Brigo, Wolfgang Löscher, Marian Galovic, Joana Moreira, Luis M Magalhães, Guillermo Castilla-Fernández, Helena Gama, Angelika Kippert, Valentina Di Foggia, Miguel M Fonseca, Nuno Pires, Daniel Ramos, Joerg Holenz, Gerhard Luef, Tim J. von Oertzen, Jörg Weber, Ummehan Ermis, Bernd Kallmünze, Holger Lerche, Carlos Martinez Quesada, Jan Rémi, Jörg B. Schulz, Yvonne Weber, Firas Fahoum, Claudia Granbichler, Stefan Mausbach, David Orion, Paolo Manganotti
Source record
Source: Crossref
Published: Mar 1, 2026
DOI: 10.1016/s1474-4422(25)00491-0
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.